FindTrial
Sign In

The observation of different dose prednisone in treating idopathic nephrotic syndrome patients over the age of 60 years old

The observation of different dose prednisone in treating idopathic nephrotic syndrome patients over the age of 60 years old

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-16008265
Enrollment
Unknown
Registered
2016-04-11
Start date
2016-03-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idopathic Nephrotic Syndrome

Interventions

Case series:Nil

Sponsors

Nephrology Department, Xiangya Hospital , Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Idopathic Nephrotic Syndrome; 2. aged >=60 years; 3. finished Renal Biopsy; 4. on prednisone therapy.

Exclusion criteria

Exclusion criteria: 1. Patients with rapidly progressive glomerulonephritis, diabetes nephropathy, systemic lupus erythematosus (SLE), nephrotic syndrome related with carcinoma, hepatitis B virus related-glomerular nephritis, or systemic vasculitis were excluded from this study; 2. no renal biopsy.

Design outcomes

Primary

MeasureTime frame
renal function;—

Countries

China

Contacts

Public ContactHui Xu

Nephrology Department Xiangya Hospital Central South University Changsha, Hunan, The People's Republic of China, 410008

xuhuiye@csu.edu.cn+86 15974199189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026